anti-CD165 antibody product blog
Tags: Antibody; Monoclonal Antibody; CD165; anti-CD165 antibody;
The CD165 n/a (Catalog #MBS601643) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CD165 (AD2) (Biotin) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CD165 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS).Suitable for use in Flow Cytometry., Recommended DilutionOptimal dilutions to be determined by the researcher. Researchers should empirically determine the suitability of the CD165 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CD165 n/a product has the following accession number(s) (GI #531234994) (NCBI Accession #EQF35291.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Human CD165 is a cell surface molecule present on a subset of peripheral lymphocytes and monocytes and is important for adhesion of thymocytes to thymic epithelial cells.
Immunogen: HSB cells
Functional Application: Antibody blocks the function of CD165. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD165 are readily searchable from our website. Different antibodies against the same target such as CD165 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.